264 related articles for article (PubMed ID: 31954604)
1. Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Paraskevopoulos I; Karnabatidis D
J Vasc Interv Radiol; 2020 Feb; 31(2):202-212. PubMed ID: 31954604
[TBL] [Abstract][Full Text] [Related]
2. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
3. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
[TBL] [Abstract][Full Text] [Related]
4. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
5. Drug-Coated Balloon Angioplasty in Clinical Practice for Below-the-Knee, Popliteal, and Crural Artery Lesions Causing Critical Limb Ischemia: 1-Year Results from the Spanish Luminor Registry.
Riambau V; Acín F; de Blas MJ; Alonso M; Giménez-Gaibar A;
Ann Vasc Surg; 2020 Jan; 62():387-396. PubMed ID: 31449955
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
[TBL] [Abstract][Full Text] [Related]
7. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.
Katsanos K; Spiliopoulos S; Paraskevopoulos I; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Apr; 23(2):356-70. PubMed ID: 26823485
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia.
Kumins NH; King AH; Ambani RN; Cho JS; Harth KC; Wong VL; Colvard B; Bose S; Thomas JP; Kashyap VS
J Vasc Surg; 2021 Nov; 74(5):1682-1688.e1. PubMed ID: 34090989
[TBL] [Abstract][Full Text] [Related]
10. Mortality After Paclitaxel-Coated Device Use in Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dinh K; Gomes ML; Thomas SD; Paravastu SCV; Holden A; Schneider PA; Varcoe RL
J Endovasc Ther; 2020 Apr; 27(2):175-185. PubMed ID: 32066315
[TBL] [Abstract][Full Text] [Related]
11. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.
Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M;
Trials; 2014 Feb; 15():63. PubMed ID: 24552184
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
[No Abstract] [Full Text] [Related]
14. Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions.
Pecoraro F; Dinoto E; Pakeliani D; Mirabella D; Ferlito F; Bajardi G
Ann Vasc Surg; 2021 Oct; 76():370-377. PubMed ID: 33951533
[TBL] [Abstract][Full Text] [Related]
15. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
16. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
Steiner S; Schmidt A; Bausback Y; Bräunlich S; Ulrich M; Banning-Eichenseer U; Scheinert D
J Endovasc Ther; 2016 Jun; 23(3):417-23. PubMed ID: 27099285
[TBL] [Abstract][Full Text] [Related]
17. Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.
Cassese S; Ndrepepa G; Liistro F; Fanelli F; Kufner S; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
JACC Cardiovasc Interv; 2016 May; 9(10):1072-80. PubMed ID: 27131439
[TBL] [Abstract][Full Text] [Related]
18. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Karnabatidis D
J Am Heart Assoc; 2018 Dec; 7(24):e011245. PubMed ID: 30561254
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
[TBL] [Abstract][Full Text] [Related]
20. Local Ultrasound to Enhance Paclitaxel Delivery After Femoral-Popliteal Treatment in Critical Limb Ischemia: The PACUS Trial.
Gandini R; Del Giudice C
JACC Cardiovasc Interv; 2016 Oct; 9(20):2147-2153. PubMed ID: 27765310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
